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It has been estimated that 1 to 2% of the population in developed countries will
experience a chronic wound over their lifespan.[1] Occurrence of chronic wounds are
particularly common in growing elderly populations and those who are suffering from
diabetes and obesity.[2] While there are several phases in wound healing (i.e., coagulation,
inflammation, proliferation, and remodeling),[3–6] chronic wounds are typically the result of
prolonged and/or uncontrolled inflammation.[2,7]

Despite this, inflammation is an

indispensable step in the wound healing process and sets the stage for proper regeneration by
staving off infection, clearing the wound site of debris, and recruiting cells to the wound that
play critical roles in tissue remodeling and re-vascularization.[3,6,8,9] In fact, studies have
shown that suppressing the inflammatory response actually hinders proper wound healing.[4,10]
Macrophages play a key role in regulating the inflammatory response and in directing the
transition to later stages of the wound healing process.[11–17] We and others believe that
regulating the time at which macrophages transition from coordinating an inflammatory
response (Figure 1a, Phase 1 (red)) to coordinating later pro-healing stages of the wound
healing process (Phase 2 (blue)) may be key to understanding the role of inflammation in
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wound healing and in developing improved treatment strategies.[18–20] For example, it is
apparent that proper healing requires an inflammatory phase that eventually transitions into
anti-inflammatory, pro-healing phases.[21,22] However, it remains unknown how the duration
of this inflammatory phase (Tih) impacts or can be used to optimize wound healing outcome.
Moreover, optimal durations are likely different for different wounds and for different patients.
This motivates the need for biomaterials that enable flexible control over the duration of this
inflammatory period, as both an investigative and clinical tool.
Here, we propose a biomaterial system designed to deliver immunomodulatory
cytokines in a manner that can potentially regulate the inflammatory period’s duration in a
flexible and on-demand manner. The inflammation phase can be initiated by establishing a
population of pro-inflammatory M1 macrophages through the delivery of proteins that recruit
macrophages and polarize them towards M1 phenotypes (Figure 1b, M0 to M1): for example,
Monocyte Chemoattractant Protein-1 (MCP-1),[23,24] and Interferon Gamma (IFN-γ).[25]
Transition from inflammatory to healing phases requires establishing a population of antiinflammatory M2 macrophages (e.g., alternatively activated M2a, Mb, and Mc phenotypes).
This can be triggered through the delivery of other proteins at the wound site: for example,
Interleukin-4 (IL-4),[26,27] and Interleukin-10 (IL-10),[26,27] (Figure 1b, M0/M1 to M2). Thus, it
may be possible to regulate the duration of the inflammatory response (Tih) through initial
deliveries of pro-inflammatory cytokines, such as MCP-1 and IFN-γ (Figure 1c, red curve),
followed by delayed deliveries of anti-inflammatory cytokines, such as IL-4 and/or IL-10
(Figure 1c, blue curve). Here, we will describe a two-compartment biomaterial system (Figure
1d) designed to: (i) initially release pro-inflammatory cytokines from an outer compartment
for the recruitment and establishment of pro-inflammatory macrophage phenotypes, (ii) allow
for an inflammatory period to continue until, (iii) a magnetic gradient is applied that deforms
the inner compartment, releasing anti-inflammatory cytokines, which would (iv) direct
macrophages to take on pro-healing phenotypes. Such a material system could enable control
2
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over the inflammatory period’s duration simply by applying a magnetic gradient (from simple
hand-held magnets or electromagnets) at the time point at which one wishes inflammation to
transition into an anti-inflammatory phase.
This two-compartment biomaterial system comprises an outer gelatin scaffold and an
inner biphasic ferrogel (Figure 2a). The outer compartment exhibited an interconnected
macroporous structure designed to permit rapid cell infiltration (Figure 2b). Also, by virtue of
being made from gelatin (a hydrolyzed form of collagen), this gelatin scaffold presents
binding motifs for cell binding, motility, and spreading.[28,29] For the inner compartment, we
utilized a biphasic ferrogel with an Fe3O4-laden region on the top half of the cylindrical gel
and an Fe3O4-free, porous, and deformable region on the bottom (Figure 2c). These biphasic
ferrogels were designed to efficiently deform in the presence of a graded magnetic field (i.e.,
in the presence of fields emanating from simple hand-held magnets or electromagnets). When
magnetically deformed, these gels would release molecular payloads stored in the Fe3O4-free
region in a magnetically triggered manner. The particular ferrogel formulation adopted here (1
wt% alginate, 7 wt% Fe3O4, 2.5 mM adipic acid dihydrazide cross-linked, freeze-dried at 20ºC) was previously shown to be optimal in terms of providing magnetically triggered
deliveries.[30,31]
The outer porous gelatin scaffold was designed to provide initial deliveries of proinflammatory cytokines and to recruit and permit the residence of macrophages. To test this
compartment’s ability to recruit and establish macrophage populations, RAW 264.7
macrophages were seeded at 10,000 cells per well in a 12-well plate on Day -1 and allowed to
establish themselves for 24 hours as a 2-dimensional (2D) colony. Then (at Day 0), gelatin
scaffolds (compartment 1, Figure 2b) were placed on top of 2D macrophage colonies and left
for 10 days so that macrophages could infiltrate the volume of the scaffold (Figure 3a). On
Day 5, some scaffolds were removed, fixed, and stained for f-actin (FITC-Phalloidin) and
nuclei (DAPI), revealing that macrophages had infiltrated and spread within the bottom
3
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volume of the gel (Figure 3b (left) and MovieS1.mov in Supporting Information). Also, by
Day 5, some Macrophages had reached the top of the gel (Figure 3b (right))). DAPI-stained
macrophages residing 1800 μm from the bottom of the gel (i.e., 200 μm from the top of the 2mm gel) were quantified using fluorescence microscopy on days 5 and 10 (Figure 3c). This
demonstrated that the macrophage populations could establish themselves and increase in
population through the volume of these scaffolds over the course of 10 days in vitro. It must
be noted that these in vitro studies utilized RAW macrophages which are more proliferative
than the native macrophages that would be recruited to this material in vivo. Thus, there is no
way of knowing if macrophage population increase vs. time is due to migration through the
material, proliferation, or some combination thereof. Additionally, the cell densities vs. time
observed here (Figure 3c) are likely higher than what would be expected in vivo. However, to
enhance macrophage populations, these scaffolds could also be loaded with cytokines that
could potentially expedite macrophage recruitment, as well as polarize them towards M1
phenotypes at early timepoints after implantation (e.g., MCP-1 and IFN-γ, respectively).
These cytokines released rapidly at early time points (Figure 3d & 3e) due to excess cytokine
being added to the outer compartment without rinsing off that excess cytokine prior to use.
The total amount of cytokine delivered could be dictated simply by loading the scaffold with
more or less cytokine (Figure 3d & 3e, comparing solid and dashed curves). Independent of
loading, pro-inflammatory cytokine release ceased after roughly 12 hours (Figure S1), well
before the times at which magnetic stimulation would be applied to trigger subsequent
deliveries of anti-inflammatory cytokines.
The inner compartment of this biomaterial system (Figure 2c) was designed to provide
delayed, on-demand, and magnetically triggered delivery of anti-inflammatory cytokines (e.g.,
IL-4 and IL-10). These biphasic ferrogels were designed so that cytokines could be loaded in
their Fe3O4-free regions and released in earnest when magnetic gradients were used to
compress the Fe3O4-free regions (Figure 4a, white region of ferrogel compresses when a
4
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hand-held magnetic is subjacently applied). See MovieS2.mov in Supporting Information for
a movie of a biphasic ferrogel being magnetically compressed repeatedly at 1.4 Hz. Cytokine
release rates prior to magnetic stimulation were kept at low levels by thoroughly rinsing
ferrogels, as to remove excess cytokines that were not well-incorporated. Additionally,
cytokine retention prior to magnetic stimulation was likely aided by the use of alginate as the
polymeric constituent of these ferrogels. Alginate is heparin-mimicking, and heparin is known
to bind strongly to a wide variety of cell-secreted proteins. In these studies, magnetic
gradients were applied over the course of 3 hours, but with different temporal profiles (Figure
4b): (i) one where a magnetic gradient was applied at a rate of 1.4 Hz continuously over 3
hours (Stimulation Profile A, top, green) and (ii) one where a magnetic gradient was applied
at a rate of 1.4 Hz intermittently, lasting for 5 minutes every hour for 3 hours (Stimulation
Profile B, bottom, red). The intermittent Profile B actually yielded higher rates of cytokine
delivery compared to the continuous Profile A (Figure 4c). This is possibly due to the fact that
magnetic compression results in release of molecules primarily contained in the macropore
space and not contained in the gel’s matrix (note that the Fe3O4-free region of these ferrogels
are highly macroporous (Figure 2c)). Thus, continuous 1.4 Hz stimulation (Profile A) may
initially purge these more available molecules from the pore space but may prohibit the
molecules in the gel from equilibrating (i.e., molecules that were purged from the macropore
space cannot be replaced by molecules contained in the matrix space due to constant 1.4 Hz
gel compression). This would result in a relatively low rate of release when averaged over 3
hours. However, intermittent stimulation (i.e., Stimulation Profile B) likely permits this reequilibrium of molecules in the 1 hour between subsequent magnetic compressions, resulting
in a distribution of molecules from the matrix to the pore space. When magnetic stimulation
continues, these relocated pore-space-molecules are efficiently purged. This may result in
higher release rates when averaged over 3 hours. While these dynamics are outside the scope
of this study, Stimulation Profile B has significant practical advantages in that it both
5
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produces higher rates of release and would be easier to implement in vivo. That is, 5 minutes
of 1.4 Hz stimulation every hour can be implemented by manually brining a hand-held
magnet close to the implant site whereas 3 hours of continuous 1.4 Hz stimulation could be
tiring if performed manually. Nevertheless, neither magnetic stimulation profile resulted in
statistically significant changes in gel mechanics (Figure S2), suggesting that magnetic
stimulation does not overly damage the gels. This leaves open the possibility of magnetically
stimulating at later time points for subsequent release busts.
Despite the fact that Stimulation Profile A produced lower rates of release than
Stimulation Profile B, it was nonetheless sufficient to significantly impact an antiinflammatory cytokine’s release profile. When loaded with 500 ng of IL-10, ferrogels
released baseline levels of IL-10 prior to day 3 but dramatically increased release rates on day
3 when stimulated using Magnetic Stimulation Profile A (Figure 4d, dashed curve). If this
delayed IL-10 release was desired on day 5 rather than 3, magnetic stimulation could be
applied on day 5 rather than day 3 (Figure 4d, solid curve). This ability to control the time at
which anti-inflammatories are earnestly released could provide a powerful tool for
investigating how the duration of the inflammatory response impacts wound healing outcome.
Magnetic stimulation can also potentially be used to repetitively deliver anti-inflammatory
cytokines on subsequent days to prevent an inflammatory response from resurging. For
example, when loaded with 1000 ng of IL-4, baseline levels of IL-4 were released prior to
magnetic stimulation. But, release rates were dramatically enhanced when stimulated on day 4
using Stimulation Profile B (Figure 4e, compare slope of curve before 96 hours to the slope
from 96 to 99 hours). The rate of IL-4 release could be subsequently enhanced on days 5 and
6 when magnetically stimulated on those days (Figure 4e, enhanced slopes at 120 and 144
hours). These magnetically stimulated release rates on days 4, 5, and 6 were significantly
higher than control gels upon which no magnetic stimulation was applied (Figure 4f). These
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studies demonstrate our ability to control the timing and rate of these anti-inflammatory
cytokine deliveries in an on-demand, magnetically prescribed manner.
The described biomaterial system could improve control over the inflammatory
response in wound healing applications by locally regulating macrophage phenotype through
carefully timed immunomodulatory cytokine deliveries. There is a growing preponderance of
evidence suggesting that regulating macrophage phenotype vs. time is critical to achieving
desired outcomes in wound healing and regenerative therapies,[32–36] and that sequenced
deliveries of immunomodulatory cytokines can provide a means for this temporal
regulation.[26,37] In fact, previous studies have designed scaffolding materials to release proand anti-inflammatory cytokines at different rates in an attempt to temporally control
macrophage phenotype.[19,38–41] While these studies yielded promising results in their ability
to influence macrophage phenotype in vivo, statistically significant improvements in
regeneration were not observed (e.g., larger or more well-organized vessels/tissues). This
could have been due to the inability to explicitly alter and optimize the timing of different
cytokine deliveries (i.e., having the delay time of anti-inflammatory cytokines be a variable
parameter between conditions). The biomaterial system described here could enable explicit
control over the timing of these deliveries, without having to alter the chemistry or structure
of the implantable scaffold material between experiments. It should be noted, however, that
with this material system’s current formulation, macrophages initially recruited to the outer
compartment may be exposed to baseline levels of anti-inflammatory cytokines diffusing out
of the inner ferrogel (Figure. 4d & 4e, IL-10 and IL-4 release is non-zero prior to magnetic
stimulation). Even though magnetically stimulated release is significantly higher than
diffusive release (Figure 4d & 4e, comparing slopes of curves with and without magnetic
stimulation), if diffusive release establishes a bioactive concentration of anti-inflammatory
cytokines, macrophages may begin to polarize towards pro-healing phenotypes prior to
magnetic stimulation. Thus, fine-tuning of the biomaterial system will be required so that
7
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rates of release prior to magnetic stimulation result in sub-bioactive anti-inflammatory
cytokine concentrations and release rates during magnetic stimulation result in bioactive
concentrations. Such fine tuning can be achieved by modifying cytokine loading and ferrogel
formulation (e.g., porosity, polymer concentration, polymer type, crosslinking density). Such
a tuned biomaterial system will need to be tested in order to verify that this material system is
capable of temporally regulating macrophage phenotype through magnetic stimulation.
In sum, we have developed a biomaterial system capable of initially delivering proinflammatory cytokines (MCP-1 and IFN-γ) from a macroporous gelatin structure capable of
facilitating macrophage infiltration and growth. The amount of inflammatory cytokine release
was dependent on the amount of cytokine loaded in the structure. This biomaterial system was
also integrated with a biphasic ferrogel that was capable of delivering anti-inflammatory
cytokines (IL-4 and IL-10) in a delayed and magnetically triggered manner, using common
hand-held magnets. The rate of magnetically stimulated delivery could be regulated by using
different magnetic stimulation profiles and the timing of delivery could be regulated simply
by choosing when to apply magnetic stimulation. This biomaterial system thus has the
potential to enable experimental investigations into how the rate and timing of pro- and antiinflammatory cytokine deliveries impact biological process critical in wound healing
applications. Finally, this material system could also provide the material means to
therapeutically implement optimized sequential cytokine deliveries, while retaining a high
degree of clinical adaptability by enabling real-time alterations in delivery profiles.

Experimental Section
Fabrication and imaging of the biomaterial system: The outer compartment gelatin
scaffolds used in these studies were purchased as 2 x 12 x 7 mm GelFoam™ sponge sheets
(Pfizer, Groton, CT) and cut into hollow disks (2-mm tall, 8-mm OD, 4-mm ID) using 8-mm
and 4-mm biopsy punches. Note that biopsy punches and GelFoam sponges were packaged
8
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sterile for cell experiments. Additionally, they were packaged in lyophilized form, allowing
them to be sputter-coated (30 seconds in gold) and imaged under Scanning Electron
Microscopy (SEM) on a Zeiss SIGMA VP Field Emission-SEM with cryogenic capability
and Energy-dispersive X-ray Spectroscopy (EDS) for elemental mapping.
The inner ferrogel compartments were made similarly to those described in Cezar et
al.[28] Briefly, alginate was dissolved in MES buffer (100 mM MES and 500 mM NaCl at pH
= 6.0) containing HOBT and AAD crosslinker and was cast with iron oxide particles and
EDC (100 mg mL-1) between two Sigmacote-treated glass plates that were separated by 2-mm
spacers. During casting (~ 1 hour), a magnet was placed against one glass plate as to pull the
iron oxide particles towards one side of the gel, yielding a biphasic structure. Individual
biphasic ferrogels were cut into 4 x 2 mm disks using a biopsy punch and then washed in 50
mL deionized water for 3 days (with water being exchanged twice a day) so that they would
fully swell and become void of residual reagents. Ferrogels were then frozen at -20 ºC
overnight and lyophilized. Lyophilized ferrogels were prepared for imaging by cross
sectioning them using a sharp razor, sputter-coating in gold, and imaging as described above
for the outer gelatin scaffolds.
Macrophage recruitment studies: In their culture flasks, RAW 264.7 mouse
macrophages were rinsed in PBS, resuspended in fresh DMEM, scraped off, collected, and
plated at 10,000 cells per well on sterile 12-well plates. Macrophages were submerged in
serum-containing DMEM and allowed to grow for 24 hours. A sterile gelatin scaffold (cut
into a hollow disk) was then placed on top of the 2D culture in well plates (fully submerged in
media) and left to recruit macrophages for 10 days. Macrophage-populated gelatin scaffolds
were analyzed by fixing them in 4% PFA for 10 minutes and washed for 5 minutes in PBS, 3
times. Scaffolds were then soaked in a 0.2% Triton X-100/PBS solution for 5 minutes to
permeabilize cell membranes, then washed for 5 minutes in fresh PBS, 3 times. Macrophage
nuclei were DAPI-stained by soaking scaffolds in a 2 μg/mL solution of DAPI in PBS for 5
9
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minutes and then washing for 5 minutes in fresh PBS, 3 times. Finally, macrophage actin
cytoskeletons were stained by soaking scaffolds in a 0.5 μg/mL solution of FITC-phalloidin in
PBS for 5 minutes and then washing for 5 minutes in fresh PBS, 3 times.
3D fluorescent image reconstructions were obtained by taking a green/blue confocal
slice every 10 μm from the bottom of the scaffold to a depth of 170 μm within the scaffold
using a Nikon TE2000E inverted confocal microscope and its associated NIS-Elements
software package. Macrophage cell density counts were taken by inverting the gels in a fresh
12-well plate so that the top of the gels faced down against the plate. Well plates were then
loaded into a BioTek Cytation 3 Cell Imaging Multi-Mode Reader which was set to capture a
blue-channel image 200 μg into the scaffold (which was 1800 μm away from the side of the
scaffold originally near the 2D macrophage culture). BioTek Gen5 software was used to
quantify DAPI-nuclei count from these blue-channel images.
Magnetic stimulation of ferrogels: Ferrogels were magnetically stimulated using 0.5”
x 0.5” x 0.5” (1.32 x 1.32 x 1.32 cm) cylindrical neodymium magnets (K&J Magnetics,
Pipersville, PA) that were integrated into a custom stimulation apparatus that enabled
repetitive and prolonged magnetic field exposures. The custom stimulation apparatus
consisted of an array of cylindrical neodymium magnets place on the teetering edge of a
variable-speed laboratory rocker’s platform (4 magnets on one edge and 4 on the opposite
edge, see MovieS2 in supporting information). This arrangement allowed 8 magnets to
oscillate up and down (proximally and distally to 8 ferrogel samples) at a rate prescribed by
the rocker’s speed. These studies all utilized the maximum rate of 1.4 Hz (i.e., one magnetic
compression every 0.71 seconds). Ferrogels were placed in Sigmacote-treated scintillation
vials and suspended above our custom stimulation apparatus with aluminum clamps. This
arrangement allowed ferrogel samples to be in close proximity to the magnetics when the
magnets were raised (though the magnets did not physically touch the vials) and far enough
away from the magnets (~10 cm) when the magnets were lowered, allowing the ferrogels to
10
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fully compress and conform back to their original un-compressed thickness between each
cycle.
Cytokine time course release studies: Outer compartment gelatin scaffolds were
unpacked and punched to shape in a lyophilized state. Thus, to load them with cytokine,
concentrated solutions of protein were prepared and added dropwise directly to the
dehydrated scaffolds. It was determined beforehand that when adding liquid to these scaffolds
in this manner, they could fully absorb no more than 40 μL of solution. Thus, when loading
the scaffolds, concentrated solutions were prepared such that the desired amount of protein to
be loaded in the scaffold be contained in 40 μL volumes (e.g., 1000 ng MCP-1 loading
required preparation of a concentrated solution of 1000 ng MCP-1 in 40 μL of PBS). So,
scaffolds were placed in Sigmacote-treated scintillation vials (to limit protein adsorption to
the surfaces of the vials) and loaded dropwise with concentrated protein solutions (MCP-1 or
IFN-γ, prepared at concentrations as described above). Scintillation vials were then capped
and the scaffolds were left overnight at room temperature to fully absorb the protein. Timecourse release studies began after overnight protein absorption when scaffolds were
submerged in 1 mL PBS with 1% BSA (t = 0). 1 mL samples were collected periodically from
the vials and reserved for analysis by freezing in 1.5 mL centrifuge tubes. After sample
removal, fresh 1 mL of PBS with 1% BSA was gently added back to the vial until the next
sample was taken. After all samples were collected (168 hours), they were thawed and
quantified for cytokine content using ELISA.
Release studies from ferrogels followed a similar procedure. As described above,
ferrogels were prepared with the final step being lyophilization, thus producing macroporous
and dehydrated samples. Dried ferrogels were placed in scintillation vials with the Fe3O4-free
region facing up. It was determined beforehand that when adding liquid to these ferrogels that
they could fully absorb no more than 20 μL of solution. They were therefore loaded using
desired weights of protein dissolved in 20 μL of PBS (e.g., 1000 ng IL-4 in 20 μL PBS).
11
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Ferrogels were left to absorb the protein overnight in capped vials. Ferrogels were then rinsed
in PBS with 1% BSA for 3 days to remove excess unincorporated protein, which reduced
unstimulated baseline release. Ferrogels were then periodically sampled as described with the
gelatin scaffolds, with sample media being fully removed and replaced with fresh media at
each timepoint. Collected samples were quantitatively analyzed for IL-4 or IL-10 release
using ELISA.
Statistical Analyses: All quantitative data presented in this communication are
represented as a mean ± standard deviation with 4 replicates (N = 4). Because only one-toone statistical comparisons were made in this study (i.e., no multiple comparisons), student ttests (two-tailed distributions, heteroscedastic) were used to calculate p-values with p < 0.05
being our benchmark for significance (Microsoft Excel).

Supporting Information
Additional experimental details and supplemental figures are provided in Supporting
Information.
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Figure 1. Regulating the inflammatory period requires initial delivery of proinflammatory cytokines followed by delayed delivery of anti-inflammatory cytokines. (a)
Schematic describing the cytokines that regulate the inflammation phase (I, red) and healing
phase (II, blue). (b) Schematic describing how M0 macrophages can be polarized into M1
(Pro-inflammatory) and/or M2 (Anti-inflammatory) phenotypes when exposed to different
cytokines. (c) Illustration of the desired cumulative release profile: initial release of
macrophage recruitment and pro-inflammation cytokines (red), followed by delivery of antiinflammatory cytokines (blue). (d) Illustration of the proposed biomaterial system (top) with
illustration key (bottom).
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Figure 2. Two-compartment biomaterial system comprises a magnetically responsive
biphasic ferrogel nested within an outer macroporous gelatin scaffold. (a) Photographs of
the 2-compartment biomaterial system at an angle (top) and from the top (bottom). (b) Crosssectional photograph (i) and SEM micrographs (ii) of the outer porous gelatin compartment.
(b) Cross-sectional photograph (i) and SEM microgarphs (ii) of the inner biphasic ferrogel
compartment. Elemental map reveals the location of iron (red) and carbon (yellow-green).
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Figure 3. The outer macroporous gelatin scaffold can recruit and harbor macrophages
and can rapidly release pro-inflammatory cytokines. (a) Schematic detailing how
macrophages were recruited to the gelatin scaffold and where in the scaffold different images
and measurements were taken. (b) Left: 3D z-stack detailing DAPI- (blue) and Phalloidin(green) stained macrophages in the bottom 170 μm of the scaffold on day 5. Right: collage
image of DAPI-stained macrophages (blue) taken 1800 μm from the bottom of the gel (200
μm from the top). (c) Quantification of macrophage density vs. time recorded 1800 microns
from the bottom of the scaffold. (d) Cumulative release vs. time for scaffolds loaded with
1000 ng (solid) and 100 ng (dashed) of MCP-1. (e) Cumulative release vs. time for scaffolds
loaded with 1000 ng (solid) and 100 ng (dashed) of IFN-γ. Inset: zoomed-in cumulative
release vs. time for scaffold loaded with 100 ng IFN-γ. Parts (c)-(e), N = 4.
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Figure 4. The inner ferrogel compartment can produce delayed, magnetically triggered
anti-inflammatory cytokine delivery profiles. (a) Illustration (left) and photographs (right)
of a biphasic ferrogel before (top) and during (bottom) magnetic compression. (b) Schematics
of the two magnetic stimulation profiles used in these studies: (top, green) a cyclic magnetic
field of 1.4 compressions per second continuously over 3 hours and (bottom, red) the same
exposure but pulsed so that gels are cyclically compressed for 5 minutes every hour. (c)
Amount released after 3 hours of stimulation profile A (green) vs. B (red). (d) Cumulative IL4 release vs. time from ferrogels that were either magnetically stimulated on day 3 (dashed) or
day 5 (solid). (e) Cumulative IL-10 release vs. time from ferrogels that were magnetically
stimulated on days 4, 5, and 6. (f) Release rates over the indicated times when magnetically
stimulated (red) vs. unstimulated (gray). For parts (c)-(f), ** and *** indicate statistically
significant differences with p < 0.01 and 0.001, respectively (N = 4).
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A two-compartment, magnetically responsive biomaterial system enables flexible control
over the duration between pro- and anti-inflammatory cytokines deliveries. The system’s
outer porous gelatin compartment can facilitate rapid infiltration and harboring of
macrophages. The system’s outer compartment can be magnetically compressed, releasing
payloads in earnest when stimulated with hand-held magnets. The combined 2-compartment
system can release sequences of cytokines where the time between these two deliveries is
controlled by the time at which a hand-held magnet is applied to the system.
Keywords: chronic wounds, drug delivery, inflammatory response, cytokine, hydrogel
A. E. Tolouei, N. Dülger, R. Ghatee, and S. M. Kennedy*
A Magnetically Responsive Biomaterial System for Flexibly Regulating the Duration
Between Pro- and Anti-Inflammatory Cytokine Deliveries
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